Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconconversion by a replicating oncolytic viral vector

Cancer Research

Volumn 61, Issue 3, 2001, Pages 864-868

  Ichikawa, Tomotsugu ^a   Petros, William P ^b   Ludeman, Susan M ^b   Fangmeier, Jim ^b   Hochberg, Fred H ^a   Colvin, O Michael ^b   Chiocca, E Antonio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; ALDOPHOSPHAMIDE; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; ONCOLYTIC VIRUS; POLYMER; VIRUS VECTOR;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOCOMPATIBLE MATERIALS; BIOTRANSFORMATION; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 CYP2B1; DECANOIC ACIDS; DRUG CARRIERS; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INJECTIONS, INTRALESIONAL; KINETICS; MICE; MICE, NUDE; PHOSPHORAMIDE MUSTARDS; POLYESTERS; PRODRUGS; RATS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035116213     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Oncolytic viruses and tumors: Turning one scourge against another
2. Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2BI and ganciclovir/herpes simplex virus thymidine kinase gene therapies
3. An oncolytic viral mutant that delivers the CYP2BI transgene and augments cyclophosphamide chemotherapy
4. Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus
5. Oxidative metabolism of cyclophosphamide: Identification of the hepatic monooxygenase catalysts of drug activation
6. The chemistry of the metabolites of cyclophosphamide
7. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma
8. Oxime derivatives of the intermediary oncostafic metabolites of cyclophosphamide and ifosfamide: Synthesis, deuterium labeling and applications to metabolite quantification
9. Quantitation of 4-hydroxycyclophosphamide/aldophosphamide, activated metabolites of cyclophosphamide
10. Gliadel wafers for treatment of brain tumors
11. Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain
12. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study
13. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis
14. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydruperoxycyclophosphamide
15. From the cover: Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
16. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
17. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
18. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovims, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
19. Diffusible cytotoxic metaholites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2BI cancer gene therapy paradigm
20. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication